ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Sonoma Pharmaceuticals Inc

Sonoma Pharmaceuticals Inc (SNOA)

2,88
-0,26
(-8,28%)
Geschlossen 27 März 9:00PM
2,88
0,00
( 0,00% )
Vor Marktöffnung: 9:00AM

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
2,88
Gebot
2,65
Fragen
3,15
Volumen
-
0,00 Tagesbereich 0,00
1,90 52-Wochen-Bereich 9,374
Marktkapitalisierung
Handelsende
2,88
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
-
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
1.684.841
Ausgegebene Aktien
1.615.765
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,96
Gewinn pro Aktie (EPS)
-2,99
Erlöse
12,74M
Nettogewinn
-4,84M

Über Sonoma Pharmaceuticals Inc

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing and commercializing differentiated therapies to patients living with chronic skin conditions. The company focuses on the development and commercialization of ther... Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing and commercializing differentiated therapies to patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes and others. The company derives revenue from the sale of products in the United States, Latin America, Europe and other countries. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Dover, Delaware, USA
Gegründet
-
Sonoma Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SNOA. The last closing price for Sonoma Pharmaceuticals was US$2,88. Over the last year, Sonoma Pharmaceuticals shares have traded in a share price range of US$ 1,90 to US$ 9,374.

Sonoma Pharmaceuticals currently has 1.615.765 shares in issue. The market capitalisation of Sonoma Pharmaceuticals is US$4,65 million. Sonoma Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.96.

SNOA Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.64-18.18181818183.523.62292.8884533.23135009CS
40.6730.31674208142.214.461.946375483.15481284CS
120.27.462686567162.684.461.916848413.14621612CS
26-0.28-8.860759493673.164.461.99339593.11614965CS
52-0.27-8.571428571433.159.3741.919651044.48969295CS
156-63.72-95.675675675766.6851.9126703716.56010265CS
260-91.32-96.942675159294.2390.81.9106004557.71832102CS

SNOA - Frequently Asked Questions (FAQ)

What is the current Sonoma Pharmaceuticals share price?
The current share price of Sonoma Pharmaceuticals is US$ 2,88
How many Sonoma Pharmaceuticals shares are in issue?
Sonoma Pharmaceuticals has 1.615.765 shares in issue
What is the market cap of Sonoma Pharmaceuticals?
The market capitalisation of Sonoma Pharmaceuticals is USD 4,65M
What is the 1 year trading range for Sonoma Pharmaceuticals share price?
Sonoma Pharmaceuticals has traded in the range of US$ 1,90 to US$ 9,374 during the past year
What is the PE ratio of Sonoma Pharmaceuticals?
The price to earnings ratio of Sonoma Pharmaceuticals is -0,96
What is the cash to sales ratio of Sonoma Pharmaceuticals?
The cash to sales ratio of Sonoma Pharmaceuticals is 0,37
What is the reporting currency for Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Sonoma Pharmaceuticals?
The latest annual turnover of Sonoma Pharmaceuticals is USD 12,74M
What is the latest annual profit for Sonoma Pharmaceuticals?
The latest annual profit of Sonoma Pharmaceuticals is USD -4,84M
What is the registered address of Sonoma Pharmaceuticals?
The registered address for Sonoma Pharmaceuticals is 850 NEW BURTON ROAD, SUITE 201, DOVER, DELAWARE, 19904
What is the Sonoma Pharmaceuticals website address?
The website address for Sonoma Pharmaceuticals is www.sonomapharma.com
Which industry sector does Sonoma Pharmaceuticals operate in?
Sonoma Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
PRTGPortage Biotech Inc
US$ 9,50
(101,70%)
1,28M
DBVTDBV Technologies SA
US$ 6,07
(55,24%)
2,23M
NTRPNextTrip Inc
US$ 7,99
(40,92%)
1
TWGTop Wealth Group Holding Ltd
US$ 0,2529
(38,35%)
24,25M
LCFYLocafy Ltd
US$ 7,00
(31,93%)
4
BTBDBT Brands Inc
US$ 0,52
(-59,06%)
74
DRCTDirect Digital Holdings Inc
US$ 0,82
(-38,35%)
166,14k
TBNKTerritorial Bancorp Inc
US$ 5,31
(-37,89%)
4
AUDCAudioCodes Ltd
US$ 6,31
(-35,61%)
18
XTIAXTI Aerospace Inc
US$ 1,72
(-30,08%)
37,58k
TWGTop Wealth Group Holding Ltd
US$ 0,2529
(38,35%)
24,25M
STSSSharps Technology Inc
US$ 0,1641
(7,47%)
12,56M
RNAZTransCode Therapeutics Inc
US$ 0,6343
(21,98%)
7,24M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 10,95
(3,11%)
6,75M
LGMKLogicMark Inc
US$ 0,0413
(-19,02%)
5,23M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen